Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Explore how diversified broad market strategies compare to target date funds for retirement. Learn key differences shaping risk, diversification, and long-term growth.
28,533 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Marvell Technology is set to report fiscal Q1 results after the close, with investors weighing AI demand, margins and...
Mortgage Forward has signed a definitive agreement to purchase First Federal Bank's third-party origination unit, exp...
Sandisk stock dropped again as memory-chip demand uncertainty echoed through the market. This guide breaks down why t...
A close look at the Columbia Research Enhanced Real Estate ETF reveals steady income sources from REITs but modest yi...
China is rebooting after a sluggish 2023-24 period, yet the idea that the next china still remains central to worldwi...
Two cloud software giants sit side by side in the growth-at-any-cost debate. This article breaks down whether should ...
A new flashpoint in the Strait of Hormuz triggers the fourth large supply shock this decade. Energy prices jump, infl...
Inflation data hints that the 2027 cost of living adjustment could be larger for retirees. Yet, higher Medicare premi...
Two retail powerhouses deliver contrasting plays for 2026: Amazon bets big on AI and cloud infrastructure, while Walm...
A small-cap data services company sparked May’s AI rally, with Innodata surging nearly 150% after a solid earnings re...
When a tech icon hints at Europe’s crown jewel, investors take notice. This article decodes why a single European sto...